Novartis AG has an extensive line of biologic drugs that can only be taken by injection, but now the pharmaceutical giant is making a bet on a “robotic pill,” a preclinical product that could make drugs like insulin available for the first time without the use of a needle.
Image: http://blogs.wsj.com
